首页> 外国专利> Homogeneous formulations comprising omega-3 polyunsaturated fatty acids (n-3 PUFA) and resveratrol for oral administration

Homogeneous formulations comprising omega-3 polyunsaturated fatty acids (n-3 PUFA) and resveratrol for oral administration

机译:口服含omega-3多不饱和脂肪酸(n-3 PUFA)和白藜芦醇的均相制剂

摘要

A composition characterized in that it comprises: a) a solvent system consisting of omega-3 polyunsaturated fatty acids or alkyl esters thereof, and an ionic emulsifier selected from the group consisting of degreased phosphatidylcholine enriched lecithin, or phosphatidylcholine enriched lecithin degreased wherein said phosphatidylcholine is present in an amount greater than 92%; and b) resveratrol, or a natural extract containing resveratrol; and which is further characterized in that resveratrol, in an amount greater than or equal to 5 mg per 1 mL of solvent system, is completely solubilized.
机译:一种组合物,其特征在于它包括:a)由omega-3多不饱和脂肪酸或其烷基酯和选自脱脂的富含磷脂酰胆碱的卵磷脂或富含磷脂酰胆碱的卵磷脂的离子乳化剂组成的溶剂系统,其中所述的磷脂酰胆碱是含量大于92%; b)白藜芦醇或含有白藜芦醇的天然提取物;并且其进一步的特征在于,每1mL溶剂体系中大于或等于5mg的白藜芦醇被完全溶解。

著录项

  • 公开/公告号ES2666836T3

    专利类型

  • 公开/公告日2018-05-08

    原文格式PDF

  • 申请/专利权人 ALFASIGMA S.P.A.;

    申请/专利号ES20140001941T

  • 发明设计人 SANTANIELLO MOSÈ;GIANNINI GIUSEPPE;

    申请日2014-06-04

  • 分类号A61K47/12;A61K9/08;A61K9/48;A61K31/05;A61K31/232;A61K45/06;A61K47/24;

  • 国家 ES

  • 入库时间 2022-08-21 12:48:34

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号